HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabio Puglisi Selected Research

trastuzumab deruxtecan

2/2022Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabio Puglisi Research Topics

Disease

93Breast Neoplasms (Breast Cancer)
04/2022 - 01/2002
62Neoplasms (Cancer)
04/2022 - 03/2002
11Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 07/2006
7Triple Negative Breast Neoplasms
04/2022 - 01/2010
7Neoplasm Metastasis (Metastasis)
02/2022 - 07/2013
6Melanoma (Melanoma, Malignant)
07/2021 - 04/2013
5Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2004
5Carcinoma (Carcinomatosis)
01/2016 - 03/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 08/2004
3Stomach Neoplasms (Stomach Cancer)
02/2022 - 12/2017
3Nausea
02/2022 - 02/2013
3Vomiting
02/2022 - 02/2013
3Disease Progression
01/2021 - 10/2014
3Inflammation (Inflammations)
11/2020 - 12/2018
3Hypertension (High Blood Pressure)
09/2015 - 05/2011
3Neutropenia
05/2015 - 10/2004
2Circulating Neoplastic Cells
01/2021 - 07/2012
2Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 03/2002
2Glioblastoma (Glioblastoma Multiforme)
12/2018 - 04/2018
2Amenorrhea
02/2014 - 07/2009
2Cardiotoxicity
01/2014 - 03/2008
2Anemia
02/2009 - 09/2007
1Adenocarcinoma
02/2022
1Hyperglycemia
01/2021
1Hyperinsulinism (Hyperinsulinemia)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021

Drug/Important Bio-Agent (IBA)

28Hormones (Hormone)IBA
04/2022 - 01/2010
14Trastuzumab (Herceptin)FDA Link
02/2022 - 11/2005
12Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2002
11Biomarkers (Surrogate Marker)IBA
04/2021 - 07/2008
8TamoxifenFDA LinkGeneric
10/2021 - 02/2011
8Bevacizumab (Avastin)FDA Link
05/2020 - 07/2006
7Pharmaceutical PreparationsIBA
02/2022 - 11/2010
7Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 10/2004
7Biological ProductsIBA
01/2019 - 06/2005
6Messenger RNA (mRNA)IBA
02/2022 - 03/2002
6Estrogen ReceptorsIBA
06/2021 - 07/2007
6Phenobarbital (Luminal)FDA Link
06/2021 - 10/2015
5human ERBB2 proteinIBA
02/2022 - 07/2010
5Estrogens (Estrogen)FDA Link
06/2021 - 06/2005
5exemestane (Aromasin)FDA Link
01/2021 - 07/2014
5AnthracyclinesIBA
01/2020 - 06/2005
5Capecitabine (Xeloda)FDA Link
01/2019 - 04/2009
4Progesterone Receptors (Progesterone Receptor)IBA
06/2021 - 02/2011
4Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2021 - 01/2018
4PlatinumIBA
05/2020 - 07/2019
4Lapatinib (GW572016)FDA Link
01/2020 - 11/2011
4Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 04/2009
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 07/2004
4taxaneIBA
04/2018 - 09/2007
4ErbB Receptors (EGF Receptor)IBA
02/2016 - 07/2010
4Thymidine PhosphorylaseIBA
06/2013 - 09/2007
3Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 09/2007
3Cisplatin (Platino)FDA LinkGeneric
11/2021 - 10/2004
3Circulating Tumor DNAIBA
05/2021 - 02/2019
3Aromatase InhibitorsIBA
01/2021 - 07/2014
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2020 - 08/2019
3Epirubicin (Ellence)FDA LinkGeneric
01/2020 - 07/2008
3eribulinFDA Link
11/2019 - 05/2017
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2018 - 07/2007
3pertuzumabIBA
04/2018 - 02/2016
3Docetaxel (Taxotere)FDA Link
01/2017 - 07/2004
2Protein Isoforms (Isoforms)IBA
01/2022 - 06/2019
2ribociclibIBA
11/2021 - 01/2018
2palbociclibIBA
11/2021 - 01/2018
2Letrozole (Femara)FDA LinkGeneric
11/2021 - 10/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2020 - 05/2015
2MicroRNAs (MicroRNA)IBA
01/2020 - 04/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 07/2006
2liposomal doxorubicin (Doxil)FDA Link
04/2013 - 03/2008
21-dodecylpyridoxal (PLD)IBA
04/2013 - 03/2008
2Taxoids (Taxanes)IBA
07/2009 - 09/2007
2Epoetin Alfa (Epogen)FDA Link
02/2009 - 09/2007
2Hemoglobins (Hemoglobin)IBA
02/2009 - 09/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 07/2004
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2022
1CateninsIBA
02/2022
1AntiemeticsIBA
02/2022
1Immunoconjugates (Immunoconjugate)IBA
02/2022
1trastuzumab deruxtecanIBA
02/2022
1SteroidsIBA
02/2022
1hydroxide ionIBA
11/2021
1cobalt hydroxideIBA
11/2021
1CobaltIBA
11/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1lenvatinibIBA
01/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2021
1EverolimusFDA Link
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021

Therapy/Procedure

52Therapeutics
02/2022 - 07/2004
37Drug Therapy (Chemotherapy)
02/2022 - 10/2004
7Adjuvant Chemotherapy
04/2022 - 07/2009
5Immunotherapy
04/2022 - 01/2018
3Radiotherapy
05/2021 - 05/2016
3Neoadjuvant Therapy
07/2020 - 08/2004
3Aftercare (After-Treatment)
10/2014 - 09/2007
2Metastasectomy
01/2021 - 11/2020
1Induction Chemotherapy
07/2021
1Transjugular Intrahepatic Portasystemic Shunt
07/2021